合理应用中成药治疗非酒精性脂肪性肝病*

doi:10.3969/j.issn.1672-5069.2017.02.002

Abstract

Zhao Wenxia，Zhang Lihui.. Application of Chinese traditional medicine in the treatment of patients with non-alcoholic fatty liver diseases[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 132-134.

[1] Zhou Y J，Li Y Y，Nie Y Q，et al． Prevalence of fatty liver disease and its risk factors in the population of South China．World J Gastroenterol，2007，13（47）:6419-6424．
[2] Fan J G，Zhu J，Li X J，et al．Prevalence of and risk factors for fatty liver in a general population of Shanghai China．J Hepatol，2005，43（3）:508-514．
[3] 张声生. 中成药临床应用指南·消化疾病分册.北京：中国中医药出版社，2016:214-220.
[4] 韩莉，赵文霞. 中成药对非酒精性脂肪肝的临床研究进展. 临床医药文献电子杂志，2016，3（16）:3320-3322.
[5] 高扬，庄伟，姜德春. 58037张门诊中成药处方用药调查研究. 中国医院用药评价与分析，2011，11（3）:283-285.
[6] 赵金凤，张志成. 门诊中成药不合理用药分析. 中国中西医结合杂志，2011，31（7）:994-995.
[7] Xu R X，Wu N Q，Li S，et al. Effects of HedanTablet on lipid profile，proprotein convertase subtilisin/kexin type 9 and high-density lipoprotein subfractions in patients with hyperlipidemia:A primary study. Chin J Integrat Med，2016，22（9）:660-665.
[8] 王鲁文，向龙奎，严少南，等. 护肝宁片治疗非酒精性脂肪肝疗效观察. 中国中西医结合消化杂志，2005，13（6）:373-375.
[9] 非酒精性脂肪性肝病的中西医结合诊治方案. 中医药导报，2015，17:28-33.
[10] 唐红敏，范越，张建，等. 复方玉芩胶囊治疗非酒精性单纯性脂肪肝临床研究. 上海中医药杂志，2006，40（6）:31-32.
[11] 刘纯钢，袁艳梅. 安络化纤丸联合还原型谷胱甘肽治疗非酒精性脂肪性肝病疗效观察. 实用肝脏病杂志，2014，17（1）:78-79.
[12] 邓银泉，范小芬，李剑平. 荷丹片治疗非酒精性脂肪性肝病临床观察. 浙江中西医结合杂志，2011，21（10）:697-699.
[13] 季光，范建高，陈建杰，等. 胆宁片治疗非酒精性脂肪性肝病的多中心随机对照临床研究. 中西医结合学报，2008，6（2）:128-133.
[14] 孟胜喜，赵文霞，张照兰，等. 降脂通络软胶囊治疗非酒精性脂肪性肝炎60例临床观察. 中医杂志，2012，53（14）:1234-1235.
[15] 赵唯含，余轶群，刘丽娟，等. 壳脂胶囊对非酒精性脂肪性肝炎大鼠肝组织PPAR-γ、IR的作用研究. 中国中西医结合消化杂志，2014，22（9）:501-505.
[16] 阙一平，周瑞芳. 胆宁片治疗非酒精性脂肪肝32例疗效观察. 中国社区医师，2011，1313（269）:121-121.
[17] 赵文霞，刘全忠，夏瑾瑜，等. 中医优化方案治疗非酒精性脂肪性肝炎的临床研究. 中国实验方剂学杂志，2011，17（23）:246-249.
[18] 赵文霞，刘君颖，孟祥林. 化痰泻浊方联合饮食运动治疗对非酒精性脂肪性肝炎患者TG、ALT及BMI的影响. 中华中医药杂志，2012，27（3）:654-656.

Application of Chinese traditional medicine in the treatment of patients with non-alcoholic fatty liver diseases

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Bao Yingjun, Ren Weixin.. Interventional therapy for patients with portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 768-769.
[2]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[3]	Shi Yingying, Wang Yuanxi.. Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
[4]	Xing Xin, Wei Zhongcao, Zhou mimi, et al.. Efficacy and safety of tauroursodeoxycholic acid and ursodeoxycholic acid combination in the treatment of patients with nonalcoholic fatty liver disease:a Meta-analysis [J]. Journal of Practical Hepatology, 2019, 22(6): 852-855.
[5]	Duan Chuyao, Chen Qingshan, Wang Liming, et al.. Clinical efficacy of ursodeoxycholic acid in treatment of patients with intrahepatic cholestasis of pregnancy [J]. Journal of Practical Hepatology, 2019, 22(6): 864-867.
[6]	Chen Meimei, Duan Xiaoyan, Cao Haixia, et al.. Improvement of clinical symptoms and serum hepatic fibrosis markers in patients with primary biliary cirrhosis by compound Biejiaruangan tablets [J]. Journal of Practical Hepatology, 2019, 22(6): 880-883.
[7]	Ma Yaqiong, Li Zhilan, Xia Bing.. Early administration of enteral nutrition and microecological agents in patients with hepatic encephalopathy [J]. Journal of Practical Hepatology, 2019, 22(6): 892-895.
[8]	Feng Wenguang, Jiang Wei, Song Guojun.. PPV-guided fluid therapy in patients with hepatolithiasis underwent partial hepatectomy [J]. Journal of Practical Hepatology, 2019, 22(6): 912-915.
[9]	Li Qiuxi, Jia Jianfeng, Huang Rui.. Clinical value of segmental pedicle hepatectomy and B-ultrasound-guided hepatectomy in the treatment of patients with hepatolithiasis [J]. Journal of Practical Hepatology, 2019, 22(6): 916-919.
[10]	Li Chuanjie, Xu Jing, Wang Liangliang, et al.. Changes of serum HBsAg levels in patients with chronic hepatitis B receiving entecavir treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 928-929.
[11]	Zhao Xieshan, Wu Chunrong, Wang Chunfeng, et al. Preliminary study on the efficacy of combination of tenofovir and Anluo Huaxian pill in the treatment of patients with HBeAg-negative chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 644-647.
[12]	Tu Jiexia, Wang An’na, Liao Ruoxi. Comparative study of interferon alpha -2b and peginterferon alpha -2a in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 648-651.
[13]	Zhang Xu Lei, Yang Qingyu, Han Qiuyu, et al. Short-term efficacy of herbal medicine in treatment of patients with nonalcoholic fatty liver disease [J]. Journal of Practical Hepatology, 2019, 22(5): 660-663.
[14]	Song Haiyan, Chen Xi, Zhang Junfei, et al. Application of vorionazole in the treatment of patients with liver failure complicated by pulmonary fungal infection [J]. Journal of Practical Hepatology, 2019, 22(5): 676-679.
[15]	Dan Zhuyongji, Liu Zhilan, Lu Yanyan, et al. Efficacy of endoscopic sequential variceal 1igation plus sclerotherapy in treatment of patients with hepatitis B-induced liver cirrhosis complicated by esophageal gastric varices bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 692-695.